Home » Biocompatibles to Buy CellMed for up to €22.2 Million
Biocompatibles to Buy CellMed for up to €22.2 Million
Biocompatibles International, the medical device company focused on the treatment of cancer and cardiovascular disease, has conditionally agreed to acquire Germany's CellMed for up to €22.2 million in cash and shares.
interactive investor (http://www.iii.co.uk/news/?type=afxnews&articleid=5227852&subject=companies&action=article)
KEYWORDS FDAnews Device Daily Bulletin
Upcoming Events
-
21Oct